Patents by Inventor Lawrence Mahan

Lawrence Mahan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230173029
    Abstract: The present invention provides a polypeptidic compound for use in prevention or treatment of cardiac remodeling in a subject, the polypeptidic compound comprising the amino acid sequence of proANP31-67, or an amino acid sequence having at least 80% sequence identity thereto.
    Type: Application
    Filed: April 2, 2020
    Publication date: June 8, 2023
    Applicants: UNIVERSITETET I OSLO, OSLO UNIVERSITETSSYKEHUS HF
    Inventors: Lawrence MAHAN, Alessandro CATALIOTTI, Raffaele ALTARA
  • Publication number: 20170143236
    Abstract: Described herein are systems and corresponding methods to place and further monitor an implanted medical device. The implanted device includes a fluorescent material that is disposed on a portion of a tip of the device. The system also includes a skin patch having one or more infrared light detectors configured to detect light radiation from the fluorescent material on the implanted device located beneath a skin surface of living tissue. The system further includes an image processing module that is configured to construct an image of the implanted device and its surroundings. The processor further registers and analyzes the position of the implanted device and provides an appropriate feedback signal to a monitoring station.
    Type: Application
    Filed: February 1, 2017
    Publication date: May 25, 2017
    Applicant: Children's National Medical Center
    Inventors: Raj Shekhar, Mahdi Azizian, Peng Cheng, Lawrence Mahan, Abby Whittington, Lissett Bickford
  • Publication number: 20150087969
    Abstract: Described herein are systems and corresponding methods to place and further monitor an implanted medical device. The implanted device includes a fluorescent material that is disposed on a portion of a tip of the device. The system also includes a skin patch having one or more infrared light detectors configured to detect light radiation from the fluorescent material on the implanted device located beneath a skin surface of living tissue. The system further includes an image processing module that is configured to construct an image of the implanted device and its surroundings. The processor further registers and analyzes the position of the implanted device and provides an appropriate feedback signal to a monitoring station.
    Type: Application
    Filed: September 22, 2014
    Publication date: March 26, 2015
    Applicant: Children's National Medical Center
    Inventors: Raj SHEKHAR, Mahdi Azizian, Peng Cheng, Lawrence Mahan, Abby Whittington, Lissett Bickford
  • Patent number: 8273024
    Abstract: An improved ultrasound transmission gel adapted to induce a therapeutic effect and/or palliative effect in a patient. An ultrasound transmission gel may include a water-based gel having a conductivity adapted to facilitate ultrasound signal transfer, and an essential oil. An essential oil may be selected according to its ability to calm and/or relieve certain medical conditions. In some embodiments, an ultrasound transmission gel may be customized to suit a particular patient's medical needs.
    Type: Grant
    Filed: March 14, 2005
    Date of Patent: September 25, 2012
    Inventors: Rita Kathleen Chew, Richard Lawrence Mahan